avg body weight lost with Semaglutide (NEJM STEP 1 trial, 68 weeks) 2025% avg body weight lost with Tirzepatide (SURMOUNT-1, 7288 weeks) of semaglutide patients lost 5% of body weight (STEP 1 trial)of semaglutide patients lost 5% of body weight (STEP 1 trial) Week 14: Appetite reduction, smaller portions naturally Month 13: Steady fat loss begins, 12 lbs/week avg Month 36: Visible body composition change, reduced visceral fat 68 weeks: Average 14.9% total body weight reduction Ozempic for weight loss and Wegovy for weight loss produce comparable outcomes at equivalent doses
Adjustments to the dosage and administration of Tirzepatide may occur to reach the maximum tolerated dose that corresponds with ongoing weight loss management
Ongoing health management Regular check-ins track your body composition, nutrient levels, and cardiometabolic health throughout the treatment
Both medications are highly effective, but tirzepatides dual action may provide an added boost for those looking to manage both diabetes and weight. However, results are totally contingent on the individuals holistic efforts (diet and exercise), Dr
